Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Topic: Minimally Invasive Surgery for HCC

A special issue of Hepatoma Research

ISSN 2454-2520 (Online), ISSN 2394-5079 (Print)

Submission deadline: 15 Aug 2020

Guest Editor(s)

  • Ho-Seong Han, MD, PhD
    Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
    President-elect of Korean Society of HBP Surgery, President of the Korean Study Group of Laparoscopic Liver Surgery, ex-Chairman of Korean Society of Endoscopic & Laparoscopic Surgery, Chairman of the Korean Society of Parenteral and Enteral Nutrition (KSPEN), Vice President of IASMEN(International Association of Surgical Metabolism and Nutrition), treasurer of IASGO.

    Website | E-mail

Special Issue Introduction

With many reports on encouraging outcomes for hepatocellular carcinoma (HCC), laparoscopic liver resection has been accepted as an attractive alternative to open liver resection for treatment for HCC. However, still laparoscopic liver resection is still considered as difficult procedure, especially for major resection. In the 1st and 2nd consensus meeting on laparoscopic liver resection meeting, it was stated that major resection still has a risk associated with its novelty. And there are several limits in technical aspects. When the tumor is located at postero-superior area, it is still difficult to perform laparoscopic liver resection. Cirrhosis is still a limiting condition for this surgery. There is also the limit in control bleeding when it occurs. However, with the accumulation of the experiences on laparoscopic liver resection, this procedure is more easily performed than before. Anatomic liver resection has been reported to have oncological benefit. And there are reports that remnant liver ischemia after liver resection has an adverse effect on survival. This procedure should be performed very precisely and meticulously. Recently, there is a new trend to perform robotic-assisted liver resection. Robotic-assisted liver resection has advantages of ergonomic conveniences and short learning curve. However, there is still a shortage of adequate equipment such as CUSA.
With the evident advantage associated with minimal invasive surgery, minimally invasive liver surgery will be performed more frequently in the future.


1. Roberto Ivan Troisi Department of clinical medicine and surgery, Federico Ⅱ University, Naples, Italy.
2. Mariano Cesare Giglio Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy.
3. Roberto Montalti Department of Public Health, Federico II University, Naples, Italy.
4. Tan To Cheung Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Queen Mary Hospital, Hongkong, China.
5. Chen-Guo Ker Department of Surgery, Yuan's General Hospital, Kaohsiung, Taiwan.
6. Zenich Morise Department of Surgery, Fujita Health University School of Medicine, Toyoake, Japan.
7. Kaichi Cheng Department of Surgery, Kwong Wah Hospital, Hong Kong, China.
8. Georgios Tsoulfas First Department of Surgery, Aristotle University of Thessaloniki, Thessaloniki, Greece.
9. Adrian Kah Heng Chiow Department of Surgery, Changi General Hospital, Singapore.
10. Giovanni Battista Levi Sandri Department of Digestive Surgery, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
11. Chuan-Dong Sun Department of HBP surgery, Affiliated hospital of Qingdao university, Qingdao, China.
12. Jonathan G. Sham Department of Surgery, Johns Hopkins Hospital, Baltimore, MD, USA.
13. Minoru Tanabe Department of Hepatobiliary and Pancreatic Surgery, Tokyo Medical and Dental University, Japan.
14. Go Wakabayashi Center for Advanced Treatment of HBP Diseases, Ageo Central General Hospital, Tokyo, Japan.
15. Kazuharu Igarashi Department of Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
16. Cipriani Federica Hepatobiliary Surgery Division, San Raffaele Hospital, Milano, Italy.
17. Nikolaos Machairas Clinic of Surgery, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
18. Georgios Charalambos Sotiropoulos Second Department of Propedeutic Surgery, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
19. Andrew N. de la Torre Division of Hepatobiliary Surgery, Liver Disease Services, Carepoint Health, Hudson County, Jersey, New Jersey.
20. Nan Li Department of Hepatic Surgery VI, Second Military Medical University, Shanghai, China.
21. Yusuke Ome Department of Gastroenterological Surgery, New Tokyo Hospital, Matsudo, Chiba, Japan.
22. Kazuki Hashida Department of Surgery, Kurashiki Central Hospital, Okayama, Japan.
23. Choon H. Yuck David Kwon Department of General Surgery, Cleveland Clinic, Cleveland, Ohio, USA.
24. Takeo Nomi Department of Surgery, Nara Medical University, Kashihara, Japan.
25. Takeshi Takahara Department of Surgery, Iwate Medical University, Yahaba, Japan.
26. Rami Rhaiem Hepatobiliary and Digestive Surgery Department, Robert Debré University Hospital, Reims, France.
27. Xiao-Ying Wang Liver Surgery Department, Liver Cancer Institute, Zhongshan Hospital, Shanghai, China.
28. Yuichiro Otsuka Division of General and Gastroenterological Surgery, Department of Surgery, Toho University, Tokyo, Japan.
29. Atsushi Sugioka Department of Surgery, Fujita Health University, Toyoake, Japan.
30. Yutaro Kato Department of Surgery, Fujita Health University, Toyoake, Japan.
31. Ilhan Karabicak Department of Surgery, Medicalpark Hospital, Samsun, Turkey.
32. Ya-Jin Chen Department of hepatobiliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
33. Ilhan Karabicak Department of Surgery, Medicalpark Hospital, Samsun, Turkey.
34. Rong Liu Department of Hepatobiliary and Pancreatic Surgical Oncology, Chinese PLA General Hospital, Beijing, China.
35. Fernando Rotellar Sastre Department of HPB Surgery, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.
36. Ruben Ciria Unit of Hepatobiliary Surgery and Liver Transplantation, University Hospital Reina Sofia, Cordoba, Spain.
37. Mohammed Abu-Hilal Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
38. Alfred Wei Chieh Kow Division of Hepatobiliary and Pancreatic Surgery, University Surgical Cluster, National University Health System, Singapore.
39. Mitsuo Miyazawa Department of Surgery, Teikyo Unoversity School of Medicine, Mizonokuchi Hospital, Futago, Itabashi, Japan.
40. Rodrigo Figueroa HPB surgery and Liver Transplat Unit, Sanatorio Allende, Córdoba, Argentina.
41. Daisuke Ban Depratment of HBP surgery, National Cancer Center Hospital, Tokyo, Japan.
42. Toshiya Kamiyama Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan.
43. Kuo-Hsin Chen General Surgery, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
44. Kin Yong Stephen Chang Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, National University Health System Singapore, National University of Singapore, Singapore, Singapore.
45. Lip Seng Lee Hepatopancreatobiliary Unit, Department of Surgery, Changi General Hospital, Singapore.
The list is arranged in no particular order and being updated.

Submission Deadline

15 Aug 2020

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 15 Aug 2020
Contacts: Victoria Lee, Assistant Editor,

Published Articles

Copyright © 2021 OAE Publishing Inc. All Rights Reserved.